New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
07:19 EDTREGNRegeneron announced Eylea injection recommended for approval in EU
Regeneron announced that EYLEA Injection has been recommended for approval by the European Committee for Medicinal Products for Human Use for the treatment of visual impairment due to diabetic macular edema. The decision of the European Commission is expected in the second half of 2014. The European Union submission is based on positive data from the Phase 3 VIVID-DME and VISTA-DME studies.
News For REGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
06:43 EDTREGNRegeneron price target raised to $527 from $445 at Leerink
Subscribe for More Information
April 20, 2015
09:20 EDTREGNLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use